4.7 Letter

Vascular endothelial growth factor levels in immunodepleted plasma of cancer patients as a possible pharmacodynamic marker for bevacizumab activity

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 25, Issue 13, Pages 1816-1818

Publisher

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2006.10.3051

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available